Spectra Clinical Research Report issue

For profit Phase 3
Founded: Rockleigh NJ United States (1982)
Status: Acquired by Fresenius (1997)

Organization Overview

First Clinical Trial
2007
NCT01187966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Spectra Clinical Research Centre, Hyderabad

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Catheter-Related Infections (Phase 3)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Kidney Failure, Chronic (Phase 3)

Parkinson Disease (Phase 3)

Renal Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4